Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2025-12-25 @ 4:52 PM
NCT ID: NCT00715403
Term: Adverse drug reaction
Organ System: General disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MEDDRA 12.0
Notes: None
Study: NCT00715403
Study Brief: A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 1 View
EG001 None 0 1 View
EG002 None 0 4 View
EG003 None 0 9 View
EG004 None 0 6 View
EG005 None 1 19 View
EG006 None 0 1 View